RIPK1 inhibitor ameliorates the MPP+/MPTP-induced Parkinson’s disease through the ASK1/JNK signalling pathway
- 30 January 2021
- journal article
- research article
- Published by Elsevier BV in Brain Research
- Vol. 1757, 147310
- https://doi.org/10.1016/j.brainres.2021.147310
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Mitochondrial Dysfunction in Parkinson’s DiseaseExperimental Neurobiology, 2015
- RIPK1 ensures intestinal homeostasis by protecting the epithelium against apoptosisNature, 2014
- Cutting Edge: RIPK1 Kinase Inactive Mice Are Viable and Protected from TNF-Induced Necroptosis In VivoThe Journal of Immunology, 2014
- Necrostatin-1 Suppresses Autophagy and Apoptosis in Mice Traumatic Brain Injury ModelNeurochemical Research, 2012
- Neuroprotective effects of black soybean anthocyanins via inactivation of ASK1–JNK/p38 pathways and mobilization of cellular sialic acidsLife Sciences, 2012
- Apoptosis Signal-Regulating Kinase 1 Mediates MPTP Toxicity and Regulates Glial ActivationPLOS ONE, 2012
- Protective Effect of Lycopene on Oxidative Stress and Cognitive Decline in Rotenone Induced Model of Parkinson’s DiseaseNeurochemical Research, 2011
- Peroxiredoxin-2 Protects against 6-Hydroxydopamine-Induced Dopaminergic Neurodegeneration via Attenuation of the Apoptosis Signal-Regulating Kinase (ASK1) Signaling CascadeJournal of Neuroscience, 2011
- Identification methods in newborn C57BL/6 mice: a developmental and behavioural evaluationLaboratory Animals, 2010
- Amyloid β induces neuronal cell death through ROS-mediated ASK1 activationCell Death & Differentiation, 2004